Paper40323138
Performance of a whole blood immunoassay for tenofovir detection and correlation with self-reported pre-exposure prophylaxis use in HIV-negative men who have sex with men interested in blood donation.
Buccheri R and 13 others. Transfusion, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Performance of a whole blood immunoassay for tenofovir detection and correlation with self-reported pre-exposure prophylaxis use in HIV-negative men who have sex with men interested in blood donation. Papers, record 40323138. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40323138
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Performance of a whole blood immunoassay for tenofovir detection and correlation with self-reported pre-exposure prophylaxis use in HIV-negative men who have sex with men interested in blood donation.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tenofovir | Major topic |
| Pre-Exposure Prophylaxis | Major topic |
| Blood Donors | Major topic |
| HIV Infections | Major topic |
| Homosexuality, Male | Major topic |
| Anti-HIV Agents | Major topic |
| Humans | |
| Male | |
| Adult | |
| Cross-Sectional Studies | |
| Middle Aged | |
| Self Report | |
| Immunoassay | |
| Blood Donation |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CC999999 | Intramural CDC HHS | United States | PubMed | |
| 75F40119P10697 | FDA HHS | United States | PubMed |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39401236 | Trends in Oral and Injectable HIV Preexposure Prophylaxis Prescriptions in the US, 2013-2023. | JAMA | 2024 | https://conductscience.org/library/papers/39401236 | PubMed |
| 2 | 15855512 | Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/15855512 | PubMed |
| 3 | 31314073 | Urine Tenofovir Concentrations Correlate With Plasma and Relate to Tenofovir Disoproxil Fumarate Adherence: A Randomized, Directly Observed Pharmacokinetic Trial (TARGET Study). | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/31314073 | PubMed |
| 4 | 36285751 | Screening for high-risk sexual behavior in Canada. | Transfusion | 2022 | https://conductscience.org/library/papers/36285751 | PubMed |
| 5 | 37741792 | HIV Pre-Exposure Prophylaxis, Blood Donor Deferral, Occult Infection, and Risk of HIV Transmission by Transfusion: A Fine Balance Between Evidence-Based Donor Selection Criteria and Transfusion Safety. | Transfus Med Rev | 2023 | https://conductscience.org/library/papers/37741792 | PubMed |
| 6 | 25065857 | Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. | Lancet Infect Dis | 2014 | https://conductscience.org/library/papers/25065857 | PubMed |
| 7 | 26624850 | On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26624850 | PubMed |
| 8 | 29334548 | Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide. | AIDS | 2018 | https://conductscience.org/library/papers/29334548 | PubMed |
| 9 | 33742745 | Tenofovir and emtricitabine concentrations in hair are comparable between individuals on tenofovir disoproxil fumarate versus tenofovir alafenamide-based ART. | Drug Test Anal | 2021 | https://conductscience.org/library/papers/33742745 | PubMed |
| 10 | 19273671 | Pilot pharmacokinetic study of human immunodeficiency virus-infected patients receiving tenofovir disoproxil fumarate (TDF): investigation of systemic and intracellular interactions between TDF and abacavir, lamivudine, or lopinavir-ritonavir. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19273671 | PubMed |
| 11 | 35301540 | Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084. | J Infect Dis | 2022 | https://conductscience.org/library/papers/35301540 | PubMed |
| 12 | 22935078 | Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. | AIDS Res Hum Retroviruses | 2013 | https://conductscience.org/library/papers/22935078 | PubMed |
| 13 | 26414912 | Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066). | AIDS Res Hum Retroviruses | 2016 | https://conductscience.org/library/papers/26414912 | PubMed |
| 14 | 29038282 | Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29038282 | PubMed |
| 15 | 28747274 | Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. | Lancet HIV | 2017 | https://conductscience.org/library/papers/28747274 | PubMed |
| 16 | 34375141 | Why Are Patients Switching from Tenofovir Disoproxil Fumarate/Emtricitabine (Truvada) to Tenofovir Alafenamide/Emtricitabine (Descovy) for Pre-Exposure Prophylaxis? | AIDS Patient Care STDS | 2021 | https://conductscience.org/library/papers/34375141 | PubMed |
| 17 | 11562963 | Metabolism of GS-7340, a novel phenyl monophosphoramidate intracellular prodrug of PMPA, in blood. | Nucleosides Nucleotides Nucleic Acids | 2001 | https://conductscience.org/library/papers/11562963 | PubMed |
| 18 | 33126825 | Altered Antibody Responses in Persons Infected with HIV-1 While Using Preexposure Prophylaxis. | AIDS Res Hum Retroviruses | 2021 | https://conductscience.org/library/papers/33126825 | PubMed |
| 19 | 34379922 | Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34379922 | PubMed |
| 20 | 28692542 | The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion. | AIDS | 2017 | https://conductscience.org/library/papers/28692542 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41802885 | Pre-exposure prophylaxis use in blood donors in England. | Vox Sang | 2026 | https://conductscience.org/library/papers/41802885 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40323138
GET https://conductscience.org/api/papers/v1/40323138/references?page=2